Materna: profile and news

Study Describes Osteonecrosis of the Jaw in Patients with Multiple ... Feb 27, 2006
Zometa® (zoledronic acid) and Aredia® (pamidronate) are two potent bisphosphonates that are approved for use in specific subsets of cancer patients. ... - Cancer Consultants (press release),

Anti-AIDS, oncology drugs to get cheaper? Feb 28, 2006
...customs duty on about 10 anti-AIDS and oncology drugs from 15% to 5%. This is expected to make a few high-cost drugs in cancer therapy like Zometa of Novartis ... - Moneycontrol.com,

Randomized Trial Shows Ganite (Gallium Nitrate Injection) ... Mar 2, 2006
While bisphosphonates such as Aredia and Zometa(R) (zoledronate; Novartis, Inc.) are the most widely prescribed drugs for cancer-related bone loss, this trial ... - DG News

Weekly Fosamax Reverses Bone Loss in Men on Anti-Androgen Therapy Feb 28, 2006
Zometa (zoledronic acid), another bisphosphonate, has been approved by the FDA for the treatment of osteoporosis in men with metastatic prostate cancer. ... - MedPage Today,

A Look at the Effects of Bisphosphonates and the Benefits It ... Feb 7, 2006
Intravenous (IV) treatment with bisphosphonates such as pamidronate (Novartis's Aredia) and zoledronic acid (Novartis's Zometa), in conjunction with standard ... - Genetic Engineering News,

Good news about osteoporosis drugs Feb 6, 2006
Early reports suggest that a yearly IV infusion of a distant relative of Boniva, called Zometa, may have comparable efficacy and may be the next injectable ... - El Paso Times,

Investigational Long-Term Osteoporosis Drug Shows Merit Feb 23, 2006
..."Another advanced-generation bisphosphonate, zoledronic acid [Zometa], is being tested in the form of a brief intravenous infusion administered yearly," he ... - MedPage Today,

Aclasta held back by FDA request for additional data Feb 27, 2006
Last year, analysts at Goldman Sachs said that Novartis' zoledronic acid franchise - which also includes Zometa for bone metastases - could achieve peak sales ... - Pharma Times (subscription),

Map of life that shames Britain Feb 16, 2006
Kent. And the new drug Zometa, which is 1,000 times more powerful than previous treatments, is not yet available in Scotland. A ... - Mirror.co.uk,

Palio Promotes Nanette Foster Feb 16, 2006
...with clients such as Adirondack Trust, AuthorHouse, First Horizon, Cephalon, GSK Oncology Franchise, GSK HIV Franchise, Zometa, Schenectady International ... - PharmaLive.com (press release),

Man from Midwest City included in plaintiffs filing 'dead jaw' ... Jan 20, 2006
The suit alleges that the drugs Aredia and Zometa cause the "dead jaw" condition -- tissue in the jaw dies -- when administered to patients with a history of ... - NewsOK.com (subscription),

(PZ) Novartis Delivers Strong Performance with Record Results in ... Jan 18, 2006
...control hypertension. Oncology net sales rose 15% (+19% lc) thanks to recent clinical data for Femara, Gleevec/Glivec and Zometa. Net ... - Houston Chronicle,

Big Pharma's Reversal of Fortune Jan 26, 2006
Similarly, Novartis has four blockbuster oncology drugs, including Femara for breast cancer, Zometa for bone complications from cancer, and chronic myeloid ... - BusinessWeek

Novartis Q4 net down slightly on impairment charges; sees record ... Jan 18, 2006
Novartis said. Oncology net sales rose by 15 pct thanks to recent clinical date for Femara, Gleevec/Glivec and Zometa, it added. Sales ... - Forbes

Loyola to study for first time IV medication for osteopenia and ... Jan 10, 2006
Loyola researchers hope that zoledronic acid, currently marketed under the brand name Zometa, will be effective and safe for patients with IBD. ... - News-Medical.net,

Cytogen Announces Publication of Peer Reviewed Preclinical Data ... Jan 24, 2006
QUADRAMET is also currently being evaluated in multiple myeloma patients in a Phase I combination trial with zoledronic acid (Zometa(R), Novartis AG). ... - PharmaLive.com (press release),

Further Evidence that Zometa® Reduces Bone Loss Associated with ... Dec 9, 2005
A multicenter trial has confirmed that Zometa (zoledronic acid) given for one year prevents bone loss in patients with metastatic prostate cancer who are ... - Cancer Consultants (press release),

Further Evidence that Zometa® Reduces Bone Loss in Prostate ... Dec 6, 2005
According to a recent article published in Urology, further evidence indicates that treatment with Zometa (zoledronic acid) for one year prevents bone loss in ... - Cancer Consultants (press release),

Zometa® Reduces and Recovers Bone Loss from Androgen Deprivation ... Nov 14, 2005
A multicenter US randomized double-blind study has demonstrated that Zometa® (zoledronic acid) reduces bone loss and recovers bone loss associated with ... - Cancer Consultants (press release),

Zometa® Reduces Bone Loss from Androgen Deprivation Therapy for ... Nov 8, 2005
Zometa® (zoledronic acid) reduces bone loss and promotes bone recovery among prostate cancer patients treated with androgen deprivation therapy, according to ... - Cancer Consultants (press release),

Long-Term Use of Bisphosphonates and Osteonecrosis of the Jaw ... Nov 30, 2005
Zometa® (zoledronic acid) and Aredia® (pamidronate) are two potent bisphosphonates that are approved for use in specific subsets of cancer patients. ... - Cancer Consultants (press release),

Risk Factors for Osteonecrosis of the Jaw from Bisphosphonates ... Dec 2, 2005
The original reports involved the use of Zometa® (zoledronic acid), but cases have now been reported after Aredia® (pamidronate). ... - Cancer Consultants (press release),

Novartis to pay up to $520M for potential cancer therapies Dec 8, 2005
Novartis already sells two widely used oncology drugs: Gleevec for treating leukemia and Zometa for treating bone metastases, each of which brought in more ... - NorthJersey.com,

Novartis to pay Astex to $520 m for drug rights Dec 6, 2005
Novartis, Europe’s second-largest drugmaker by market value, already sells oncology drugs including Gleevec and Zometa, both of which brought in more than $1 ... - Financial Express,

Cancer patient fights to make 60 Dec 1, 2005
...from dividing. On alternating Fridays, she also receives Taxotere, a chemotherapy, and Zometa, a bone-strengthener. Occasionally ... - DesMoinesRegister.com,

NHS puts cost before patients' lives Nov 12, 2005
Doctors believe the two drugs, called Zometa and Taxotere, could slow his cancer and they are already available on the NHS to women with breast cancer. ... - Scotsman,

Pfizer's Troubles Pull Down Drugmakers Nov 21, 2005
...revenues from patented pharmaceuticals rose 11%, thanks in part to a 23% increase in sales of oncology drugs like Diovan, Gleevec, Lotrel, Femara, and Zometa. ... - Chemical & Engineering News

Beatson rejects call to stop using costly cancer drug Nov 8, 2005
The news is a further blow to prostate cancer sufferers after the SMC last year rejected another drug, Zometa, which can help prevent bone tumours. ... - Glasgow Evening Times,

HEALTH CHIEFS' BAN ON PROSTATE CANCER DRUG Nov 7, 2005
Border. In February, the SMC also decided not to approve the drug Zometa, despite being available in England and other EU countries. ... - Glasgow Daily Record,

Men spared side effect from pain reliever Nov 10, 2005
Although quite rare, this complication appears more likely when Aredia or Zometa is given intravenously to treat cancer patients. ... - Bradenton Herald,

Drug for Bone Disease Linked to 'Jaw Death' Oct 3, 2005
Most cases occurred in cancer patients taking the intravenous bisphosphonates Aredia and Zometa to prevent cancer-related bone loss. ... - WebMD

Warning for bisphosphonates users Sep 28, 2005
The latest generation of bisphosphonates includes: alendronate (Fosamax(R)); pamidronate (Aredia(R)); and zoledronate (Zometa(R)). Bisphosphonates help ... - myDNA.com,

Critical Information for Patients About Possible Side Effect of ... Sep 28, 2005
The latest generation of bisphosphonates includes: alendronate (Fosamax®); pamidronate (Aredia®); and zoledronate (Zometa®). ... - Newswise (press release)

Novartis Will Ask FDA to Approve Heart, Diabetes Drugs in 2006 Sep 19, 2005
...company. Still, of these treatments, only cancer medicines Zometa and Gleevec brought in more than $1 billion in sales last year. ... - Bloomberg

Novartis seeks FDA nod for new drugs Sep 20, 2005
...company. Still, of these treatments, only cancer medicines Zometa and Gleevec brought in more than US$1 billion in sales last year. ... - New Straits Times,